ETF Managers Group LLC acquired a new position in HilleVax, Inc. (NASDAQ:HLVX – Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 10,857 shares of the company’s stock, valued at approximately $179,000.
A number of other large investors have also added to or reduced their stakes in HLVX. UBS Group AG increased its stake in HilleVax by 9,300.0% in the 4th quarter. UBS Group AG now owns 1,692 shares of the company’s stock worth $28,000 after acquiring an additional 1,674 shares during the last quarter. Shell Asset Management Co. bought a new stake in HilleVax in the 4th quarter worth approximately $41,000. Gyon Technologies Capital Management LP bought a new stake in HilleVax in the 4th quarter worth approximately $53,000. American International Group Inc. bought a new position in shares of HilleVax during the 2nd quarter valued at approximately $66,000. Finally, Point72 Hong Kong Ltd bought a new position in shares of HilleVax during the 2nd quarter valued at approximately $76,000. Institutional investors own 92.32% of the company’s stock.
HilleVax Stock Performance
NASDAQ HLVX opened at $17.19 on Friday. The company has a market cap of $673.85 million, a P/E ratio of -4.58 and a beta of 0.04. The company has a debt-to-equity ratio of 0.06, a quick ratio of 14.00 and a current ratio of 14.00. The business’s 50 day moving average price is $15.97 and its 200-day moving average price is $15.63. HilleVax, Inc. has a fifty-two week low of $10.00 and a fifty-two week high of $24.42.
HilleVax Profile
HilleVax, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus and related illness. The company was formerly known as MokshaCo, Inc and changed its name to HilleVax, Inc in February 2021.
Further Reading
- Five stocks we like better than HilleVax
- MarketBeat Week in Review – 6/26 – 6/30
- Tesla: Can Downgrades Make Sense After A 170% Rally?
- Buffett’s Berkshire Increases Stake In Occidental Petroleum (OXY)
- Rally Gains Momentum On Soft PCE Data
- Bank of America, JPMorgan, Goldman Sachs Set For Dividend Growth?
Receive News & Ratings for HilleVax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HilleVax and related companies with MarketBeat.com's FREE daily email newsletter.
